Advances in Melanoma: From Biology to Therapy

黑色素瘤的进展：从生物学到治疗

• 批准号: 8785875
• 负责人: Margaret Foti
• 金额: $ 0.4万
• 依托单位: AMERICAN ASSOCIATION FOR CANCER RESEARCH
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-06 至 2015-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8785875
• 关键词: Academia; Address; Basic Science; Biology; Clinic; Clinical; Combined Modality Therapy; Communities; Development; Drug resistance; Epigenetic Process; Fostering; Genetic; Goals; Hour; Industry; Knowledge; Learning; Minor; Participant; Pathogenesis; Philadelphia; Physicians; Research; Research Personnel; Resistance; Scientist; Skin Cancer; Students; Therapeutic; Time; Translating; Translational Research; Work; advanced disease; clinical practice; effective therapy; melanoma; novel; novel strategies; novel therapeutic intervention; peer; posters; public health relevance; response; symposium; therapy resistant

DESCRIPTION (provided by applicant): The proposed conference, titled "Advances in Melanoma: From Biology to Therapy," will be held from September 20-23, 2014 at the Loews Philadelphia, Philadelphia, PA. This special conference will address the unique issues and challenges in investigating and effectively treating melanoma. The goal of this conference is to bring together the top basic, translational, and clinical researchers in the field to discuss how basic research findings can be translated effectively into novel treatment options in the clinic. Scientific sessions will consist of seven presentations in major session (four hours) and three presentations in minor (two hours) sessions from expert researchers. Each presentation from expert researchers will be 20-25 minute presentations long. Additionally, to encourage young investigators one to two proffered short talk 15-20 minute will be incorporated in each session with ample time for discussion. Conference will start with presentations covering the advances in genetics, epigenetics, pathogenesis of melanoma biology, leading the discussion into principles of response and resistance to therapy-currently a major problem, concluding the discussion on emerging new strategies of using combination therapy. A special one-hour panel discussion will focus on challenges and opportunities in the melanoma research. Poster sessions will be held to allow investigators to present and discuss their latest research in an informal setting. This conference will appeal to investigators focused on the basic, translational, and clinical aspects of melanoma and will foster collaborative interdisciplinary interactions to stimulate the development of new research and clinical practices. It is expected that this new conference will provide a unique forum for discussions that will further the basic, translational, and clinical goals of the field.

描述（由申请人提供）：拟议的会议，题为“黑色素瘤的进展：从生物学到治疗”，将于2014年9月20日至23日在洛伊斯费城，费城，宾夕法尼亚州举行。这次特别会议将讨论调查和有效治疗黑色素瘤的独特问题和挑战。本次会议的目标是汇集该领域的顶级基础，转化和临床研究人员，讨论如何将基础研究成果有效地转化为临床上的新治疗方案。科学会议将包括主要会议（四小时）的七个演讲和专家研究人员的次要会议（两小时）的三个演讲。专家研究人员的每个演讲将是20-25分钟的演讲。此外，为了鼓励年轻的研究人员，每次会议将包括一至两个15-20分钟的简短演讲，并有足够的时间进行讨论。会议将首先介绍遗传学、表观遗传学、黑色素瘤生物学发病机制的进展，讨论目前主要的问题--对治疗的反应和抵抗原则，最后讨论联合治疗的新策略。一个小时的特别小组讨论将集中在黑色素瘤研究的挑战和机遇。将举行海报会议，使研究人员能够在非正式的环境中介绍和讨论他们的最新研究。这次会议将呼吁调查人员集中在基本的，翻译， 和黑色素瘤的临床方面，并将促进合作的跨学科互动，以刺激新的研究和临床实践的发展。预计这次新的会议将提供一个独特的讨论论坛，进一步推动该领域的基本，转化和临床目标。